In some way, I am disappointed at Geert. He sounds so sure about winning the hearing and now, another six months delay. No wonder why some investors don't trust him or CVM. This thing will be dragged out for months so it is off the table as far as funding the PIII trial. Let the dilution begins for $25M to $30M at $.90 each which will keep the stock price down another year or so. What else can I expect?
News 
Market Data 
Discover 
